Application of ELISA Kits in In Vitro Diagnostics and Key Points for Quality Assessment

Technical Basis and Detection Principles

Enzyme-linked immunosorbent assay (ELISA) kits are commonly used immunoassay products that rely on specific antigen-antibody binding and enzyme-catalyzed substrate color development for quantitative or qualitative analysis. The general procedure includes coating, blocking, sample addition, incubation, washing, addition of enzyme-labeled antibody, color development, and termination and reading. Because the reaction system is carried out in microplates, the operation is relatively standardized and suitable for medium-throughput sample testing, and it is widely used in scenarios such as cytokines, hormones, pathogen antibodies, and drug residues.

Different kits may use direct, indirect, sandwich, or competitive methods. The sandwich method is often used for larger molecular antigens and has relatively high specificity and sensitivity; the competitive method is mostly used for small-molecule haptens. Before selection, the molecular weight of the analyte, sample type, and expected concentration range should be clarified to ensure that the detection system is matched.

Common Types and Application Directions

According to the label and reaction mode, ELISA kits can be divided into sandwich, indirect, competitive, and other methods; according to the detection purpose, they can also be divided into quantitative, semi-quantitative, and qualitative. In in vitro diagnostics and biopharmaceutical R&D, common applications include:

Quantitative detection of inflammatory factors, tumor markers, hormones, etc. in serum or plasma;

Auxiliary screening and epidemiological investigation of antibodies or antigens for infectious diseases;

Monitoring of biopharmaceutical process residues such as host cell proteins and Protein A;

Analysis of specific small-molecule residues in food safety and environmental samples.

The above applications have relatively high requirements for indicators such as lot-to-lot consistency, matrix effects, and lower limit of quantification of the kits, and evaluation should be carried out in combination with the actual sample type.

Technical Indicators to Consider When Selecting Kits

When purchasing or validating ELISA kits, it is generally recommended to pay attention to the following parameters:

Standard curve range and fitting model: should cover the expected sample concentration, and an appropriate four-parameter or linear fitting method should be selected;

Sensitivity and lower limit of detection: usually expressed as blank limit, detection limit, or lower limit of quantification, and should be evaluated in combination with the sample dilution factor;

Precision: includes intra-assay variation and inter-assay variation, generally required to fluctuate within a small range;

Recovery and linear dilution: used to determine the degree of interference of the sample matrix on detection;

Specificity: whether cross-reactivity with structurally similar substances is within an acceptable range.

It should be noted that specific performance data should be based on the manufacturer's instructions and factory inspection reports, and laboratories should perform necessary performance verification before putting the product into use.

Laboratory Operation and Quality Control

Standardized operation has a significant impact on the stability of ELISA results. Steps such as sample volume, incubation temperature and time, number and strength of plate washing, and color development termination time should be strictly controlled. It is recommended to use calibrated pipettes and avoid mixing reagents from different lot numbers.

In each batch of testing, it is advisable to set up a standard curve, quality control samples, blank wells, and necessary replicate wells. Quality control samples can use commercial controls or laboratory-prepared samples, and Levey-Jennings quality control charts should be established to monitor drift and trends. If abnormal absorbance, poor standard curve fitting, or quality control outside the acceptable range occurs, result reporting should be stopped and the cause should be investigated.

Regulations and Document Management

For ELISA kits used in the fields of in vitro diagnostics or pharmaceutical quality control, if used for clinical diagnosis, they should generally have the corresponding medical device registration certificate or filing certificate; products for research use should have a clear "for research use only" label. Laboratories should retain kit instructions, batch inspection reports, acceptance records, and usage logs to ensure traceability. For biopharmaceutical release testing, method validation should also be carried out according to pharmacopoeias or relevant guidelines.

Overall, as a mature and widely used immunoassay tool, the detection quality of ELISA kits depends not only on the product itself but is also affected by many aspects such as sample processing, operational standardization, environmental conditions, and the quality control system. Practitioners should combine the specific detection purpose and sample characteristics, comprehensively evaluate technical indicators and regulatory requirements, and establish stable operating procedures and quality control strategies in order to obtain reliable and reproducible results.